1. Home
  2. SONN vs NDLS Comparison

SONN vs NDLS Comparison

Compare SONN & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONN
  • NDLS
  • Stock Information
  • Founded
  • SONN N/A
  • NDLS 1995
  • Country
  • SONN United States
  • NDLS United States
  • Employees
  • SONN N/A
  • NDLS N/A
  • Industry
  • SONN Biotechnology: Pharmaceutical Preparations
  • NDLS Restaurants
  • Sector
  • SONN Health Care
  • NDLS Consumer Discretionary
  • Exchange
  • SONN Nasdaq
  • NDLS Nasdaq
  • Market Cap
  • SONN 32.4M
  • NDLS 29.8M
  • IPO Year
  • SONN N/A
  • NDLS 2013
  • Fundamental
  • Price
  • SONN $3.20
  • NDLS $0.68
  • Analyst Decision
  • SONN Strong Buy
  • NDLS Buy
  • Analyst Count
  • SONN 1
  • NDLS 2
  • Target Price
  • SONN $20.00
  • NDLS $3.00
  • AVG Volume (30 Days)
  • SONN 503.8K
  • NDLS 2.1M
  • Earning Date
  • SONN 12-16-2025
  • NDLS 11-05-2025
  • Dividend Yield
  • SONN N/A
  • NDLS N/A
  • EPS Growth
  • SONN N/A
  • NDLS N/A
  • EPS
  • SONN N/A
  • NDLS N/A
  • Revenue
  • SONN $1,000,000.00
  • NDLS $494,752,000.00
  • Revenue This Year
  • SONN $5,376.22
  • NDLS $1.19
  • Revenue Next Year
  • SONN N/A
  • NDLS N/A
  • P/E Ratio
  • SONN N/A
  • NDLS N/A
  • Revenue Growth
  • SONN 1689.52
  • NDLS N/A
  • 52 Week Low
  • SONN $1.08
  • NDLS $0.55
  • 52 Week High
  • SONN $19.30
  • NDLS $1.74
  • Technical
  • Relative Strength Index (RSI)
  • SONN 38.92
  • NDLS 48.64
  • Support Level
  • SONN $4.42
  • NDLS $0.63
  • Resistance Level
  • SONN $5.15
  • NDLS $0.82
  • Average True Range (ATR)
  • SONN 0.63
  • NDLS 0.12
  • MACD
  • SONN -0.07
  • NDLS -0.01
  • Stochastic Oscillator
  • SONN 2.93
  • NDLS 12.64

About SONN Sonnet BioTherapeutics Holdings Inc.

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

About NDLS Noodles & Company

Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.

Share on Social Networks: